NIVF

NewGenIvf
NIVF

$0.6470

2.49%

Market Cap: $6.57M

About: NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.

Employees: 70

0

Funds holding %

of 6,728 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

1.24% more ownership

Funds ownership: 0% [Q1] → 1.24% (+1.24%) [Q2]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for NIVF.

See Analyst Rankings

Financial journalist opinion

NewGenIvf Announces Filing of 2023 Annual Report with the SEC

Total Revenues Reach US$5.1 Million Gross Profit Increases by 9.4% to US$1.7 Million Net Income of US$0.1 million

NewGenIvf Announces Filing of 2023 Annual Report with the SEC

NewGenIvf Provides Update on Potential Reverse Merger with COVIRIX

BANGKOK, July 24, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced an update on its proposed reverse merger (the “Proposed Transaction”) with pharmaceutical company COVIRIX Medical Pty Ltd ("COVIRIX"). The Company reports steady progress in its due diligence efforts and, contingent upon meeting all regulatory requirements, anticipates completing the Proposed Transaction by the end of August 2024.

NewGenIvf Provides Update on Potential Reverse Merger with COVIRIX

NewGenIvf Receives Nasdaq Notifications Regarding Market Value of Publicly Held Shares and Market Value of Listed Securities

BANGKOK, May 28, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), today announced that on May 24, 2024, the Company received two letters from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is currently not in compliance with certain requirements under the relevant Nasdaq Listing Rules.

NewGenIvf Receives Nasdaq Notifications Regarding Market Value of Publicly Held Shares and Market Value of Listed Securities

3 Obstacles Investors Face When Buying Penny Stocks

Penny stocks represent a unique opportunity for investors aiming to expand their portfolios without a significant initial investment. Trading penny stocks can yield high returns due to their low purchase price, making them an appealing option for both seasoned traders and newcomers to the stock market.

3 Obstacles Investors Face When Buying Penny Stocks

Why Is NewGenIvf (NIVF) Stock Up 60% Today?

Investors in NewGenIvf (NASDAQ: NIVF ) certainly have plenty to cheer today. Shares of NIVF stock were up over 60% in early afternoon trading and more than 100% at one point during today's session.

Why Is NewGenIvf (NIVF) Stock Up 60% Today?

NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with European Wellness Investment Holdings

BANGKOK, Thailand, April 22, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced the execution of a non-binding term sheet (the "Term Sheet") regarding a proposed reverse merger (the “Proposed Transaction”) with healthcare company European Wellness Investment Holdings Limited ("EWIHL").

NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with European Wellness Investment Holdings

See News Rankings